Assembly Bill A5852A

2025-2026 Legislative Session

Requires manufacturers or distributers of kratom within the state to include a warning label; prohibits labeling of kratom products as all natural

download bill text pdf

Sponsored By

Current Bill Status - Passed Senate & Assembly

  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions
Votes

Bill Amendments

co-Sponsors

multi-Sponsors

2025-A5852 - Details

See Senate Version of this Bill:
S8285
Law Section:
General Business Law
Laws Affected:
Add §398-g, Gen Bus L

2025-A5852 - Summary

Requires manufacturers of kratom products within the state to have a warning label that the product has not been approved by the federal food and drug administration and the products' side effects; prohibits labeling of kratom products as all natural.

2025-A5852 - Bill Text download pdf 

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   5852
 
                        2025-2026 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             February 24, 2025
                                ___________
 
 Introduced  by  M.  of  A. STECK, WALSH -- read once and referred to the
   Committee on Consumer Affairs and Protection
 
 AN ACT to amend the general business law,  relating  to  regulating  the
   sale of kratom products
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:

   Section 1. The general business law is amended by adding a new section
 398-g to read as follows:
   § 398-G. KRATOM PACKAGE LABELING. 1. FOR THE PURPOSES OF THIS SECTION,
 THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEANINGS:
   (A) "KRATOM" MEANS BOTH MITRAGYNA SPECIOSA, A TREE NATIVE TO SOUTHEAST
 ASIA, AND THE PRODUCTS DERIVED FROM ITS  LEAVES  THAT  ARE  MARKETED  AS
 HERBAL SUPPLEMENTS.
   (B) "ALL NATURAL" MEANS A PRODUCT THAT CONTAINS NO ARTIFICIAL INGREDI-
 ENTS OR ADDED COLORS AND IS MINIMALLY PROCESSED.
   2.  ON  EACH  PACKAGE  OF  ANY  KRATOM  PRODUCT SOLD OR DELIVERED BY A
 MANUFACTURER OR DISTRIBUTOR WITHIN THIS STATE ON OR AFTER JANUARY FIRST,
 TWO THOUSAND TWENTY-SIX, THERE SHALL  BE  PRINTED  THEREON  OR  ATTACHED
 THERETO A WARNING OF SUCH PRODUCT'S LACK OF FEDERAL FOOD AND DRUG ADMIN-
 ISTRATION  APPROVAL  AND SUCH KRATOM PRODUCTS' KNOWN SIDE EFFECTS.  SUCH
 WARNING SHALL BE IN A FONT NOT LESS THAN EIGHT-POINT TYPE AND IN A COLOR
 IN CONTRAST WITH THE PACKAGE CONTAINING SUCH KRATOM PRODUCT,  AND  SHALL
 CONTAIN THE FOLLOWING STATEMENT:
                                 "WARNING
 THIS  PRODUCT HAS NOT BEEN APPROVED BY THE FDA. SIDE EFFECTS MAY INCLUDE
 NAUSEA, AGITATION, HALLUCINATIONS, DIFFICULTY BREATHING,  LIVER  DAMAGE,
 AND DEATH"
   3. NO KRATOM PRODUCT SHALL BE ADVERTISED AS NOR SHALL THE PACKAGING OF
 SUCH KRATOM PRODUCT SUGGEST, STATE, OR IMPLY THAT SUCH KRATOM PRODUCT IS
 ALL NATURAL.

  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD09239-01-5
 A. 5852                             2

co-Sponsors

multi-Sponsors

2025-A5852A (ACTIVE) - Details

See Senate Version of this Bill:
S8285
Law Section:
General Business Law
Laws Affected:
Add §398-g, Gen Bus L

2025-A5852A (ACTIVE) - Summary

Requires manufacturers of kratom products within the state to have a warning label that the product has not been approved by the federal food and drug administration and the products' side effects; prohibits labeling of kratom products as all natural.

2025-A5852A (ACTIVE) - Bill Text download pdf 

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  5852--A
 
                        2025-2026 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             February 24, 2025
                                ___________
 
 Introduced by M. of A. STECK, WALSH, GLICK, BUTTENSCHON, K. BROWN, GRIF-
   FIN  --  Multi-Sponsored  by  --  M.  of A. LEVENBERG -- read once and
   referred to the  Committee  on  Consumer  Affairs  and  Protection  --
   committee  discharged,  bill amended, ordered reprinted as amended and
   recommitted to said committee

 AN ACT to amend the general business law,  relating  to  regulating  the
   sale of kratom products
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. The general business law is amended by adding a new section
 398-g to read as follows:
   § 398-G. KRATOM PACKAGE LABELING. 1. FOR THE PURPOSES OF THIS SECTION,
 THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEANINGS:
   (A) "KRATOM" MEANS BOTH MITRAGYNA SPECIOSA, A TREE NATIVE TO SOUTHEAST
 ASIA, AND THE PRODUCTS DERIVED FROM ITS  LEAVES  THAT  ARE  MARKETED  AS
 HERBAL SUPPLEMENTS.
   (B) "ALL NATURAL" MEANS A PRODUCT THAT CONTAINS NO ARTIFICIAL INGREDI-
 ENTS OR ADDED COLORS AND IS MINIMALLY PROCESSED.
   2.  ON  EACH  PACKAGE  OF  ANY  KRATOM  PRODUCT SOLD OR DELIVERED BY A
 MANUFACTURER WITHIN THIS STATE ON OR AFTER JANUARY FIRST,  TWO  THOUSAND
 TWENTY-SIX, THERE SHALL BE PRINTED THEREON OR ATTACHED THERETO A WARNING
 OF  SUCH PRODUCT'S LACK OF FEDERAL FOOD AND DRUG ADMINISTRATION APPROVAL
 AND SUCH KRATOM PRODUCTS' KNOWN SIDE EFFECTS.  SUCH WARNING SHALL BE  IN
 A  FONT  NOT LESS THAN TWELVE-POINT TYPE AND IN A COLOR IN CONTRAST WITH
 THE PACKAGE CONTAINING  SUCH  KRATOM  PRODUCT,  AND  SHALL  CONTAIN  THE
 FOLLOWING STATEMENT:
                                 "WARNING
 THIS  PRODUCT HAS NOT BEEN APPROVED BY THE FDA. SIDE EFFECTS MAY INCLUDE
 NAUSEA, AGITATION, HALLUCINATIONS, DIFFICULTY BREATHING,  LIVER  DAMAGE,
 AND DEATH"

  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD09239-02-5
 A. 5852--A                          2

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.